BioCentury
ARTICLE | Clinical News

Bestatin ubenimex: Phase II started

August 8, 2016 7:00 AM UTC

Eiger began the double-blind, placebo-controlled, U.S. Phase II ULTRA trial to evaluate thrice-daily 150 mg oral Bestatin ubenimex for 24 weeks in about 40 patients. In 2015, Nippon granted Eiger righ...